-
Je něco špatně v tomto záznamu ?
Molecular Mechanisms of the Interactions of N-(2-Hydroxypropyl)methacrylamide Copolymers Designed for Cancer Therapy with Blood Plasma Proteins
L. Janisova, A. Gruzinov, OV. Zaborova, N. Velychkivska, O. Vaněk, P. Chytil, T. Etrych, O. Janoušková, X. Zhang, C. Blanchet, CM. Papadakis, DI. Svergun, SK. Filippov,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
17-009735
Grantová Agentura České Republiky
15-10527J
Grantová Agentura České Republiky
Pa771/17-1
Deutsche Forschungsgemeinschaft
UNCE 204025/2012
Grantová Agentura, Univerzita Karlova
LTC17065
Ministry of Education, Youth and Sports of the Czech Republic
POLYMAT LO1507
Ministry of Education, Youth and Sports of CR
17-13283S
Grantová Agentura České Republiky
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
- Publikační typ
- časopisecké články MeSH
The binding of plasma proteins to a drug carrier alters the circulation of nanoparticles (NPs) in the bloodstream, and, as a consequence, the anticancer efficiency of the entire nanoparticle drug delivery system. We investigate the possible interaction and the interaction mechanism of a polymeric drug delivery system based on N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers (pHPMA) with the most abundant proteins in human blood plasma-namely, human serum albumin (HSA), immunoglobulin G (IgG), fibrinogen (Fbg), and apolipoprotein (Apo) E4 and A1-using a combination of small-angle X-ray scattering (SAXS), analytical ultracentrifugation (AUC), and nuclear magnetic resonance (NMR). Through rigorous investigation, we present evidence of weak interactions between proteins and polymeric nanomedicine. Such interactions do not result in the formation of the protein corona and do not affect the efficiency of the drug delivery.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20005267
- 003
- CZ-PrNML
- 005
- 20200527111608.0
- 007
- ta
- 008
- 200511s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/pharmaceutics12020106 $2 doi
- 035 __
- $a (PubMed)32013056
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Janisova, Larisa $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského sq. 2, 16206 Prague, Czech Republic.
- 245 10
- $a Molecular Mechanisms of the Interactions of N-(2-Hydroxypropyl)methacrylamide Copolymers Designed for Cancer Therapy with Blood Plasma Proteins / $c L. Janisova, A. Gruzinov, OV. Zaborova, N. Velychkivska, O. Vaněk, P. Chytil, T. Etrych, O. Janoušková, X. Zhang, C. Blanchet, CM. Papadakis, DI. Svergun, SK. Filippov,
- 520 9_
- $a The binding of plasma proteins to a drug carrier alters the circulation of nanoparticles (NPs) in the bloodstream, and, as a consequence, the anticancer efficiency of the entire nanoparticle drug delivery system. We investigate the possible interaction and the interaction mechanism of a polymeric drug delivery system based on N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers (pHPMA) with the most abundant proteins in human blood plasma-namely, human serum albumin (HSA), immunoglobulin G (IgG), fibrinogen (Fbg), and apolipoprotein (Apo) E4 and A1-using a combination of small-angle X-ray scattering (SAXS), analytical ultracentrifugation (AUC), and nuclear magnetic resonance (NMR). Through rigorous investigation, we present evidence of weak interactions between proteins and polymeric nanomedicine. Such interactions do not result in the formation of the protein corona and do not affect the efficiency of the drug delivery.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Gruzinov, Andrey $u European Molecular Biology Laboratory, Deutsches Elektronen-Synchrotron, Notkestr. 85, 22607 Hamburg, Germany.
- 700 1_
- $a Zaborova, Olga V $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského sq. 2, 16206 Prague, Czech Republic. Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, Russia.
- 700 1_
- $a Velychkivska, Nadiia $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského sq. 2, 16206 Prague, Czech Republic.
- 700 1_
- $a Vaněk, Ondřej $u Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840 Prague, Czech Republic.
- 700 1_
- $a Chytil, Petr $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského sq. 2, 16206 Prague, Czech Republic.
- 700 1_
- $a Etrych, Tomáš $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského sq. 2, 16206 Prague, Czech Republic.
- 700 1_
- $a Janoušková, Olga $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského sq. 2, 16206 Prague, Czech Republic.
- 700 1_
- $a Zhang, Xiaohan $u Fachgebiet Physik weicher Materie, Physik-Department, Technische Universität München, James-Franck-Str. 1, 85748 Garching, Germany.
- 700 1_
- $a Blanchet, Clement $u European Molecular Biology Laboratory, Deutsches Elektronen-Synchrotron, Notkestr. 85, 22607 Hamburg, Germany.
- 700 1_
- $a Papadakis, Christine M $u Fachgebiet Physik weicher Materie, Physik-Department, Technische Universität München, James-Franck-Str. 1, 85748 Garching, Germany.
- 700 1_
- $a Svergun, Dmitri I $u European Molecular Biology Laboratory, Deutsches Elektronen-Synchrotron, Notkestr. 85, 22607 Hamburg, Germany.
- 700 1_
- $a Filippov, Sergey K $u Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, USA.
- 773 0_
- $w MED00186380 $t Pharmaceutics $x 1999-4923 $g Roč. 12, č. 2 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32013056 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200527111605 $b ABA008
- 999 __
- $a ind $b bmc $g 1524197 $s 1095322
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 12 $c 2 $e 20200128 $i 1999-4923 $m Pharmaceutics $n Pharmaceutics $x MED00186380
- GRA __
- $a 17-009735 $p Grantová Agentura České Republiky
- GRA __
- $a 15-10527J $p Grantová Agentura České Republiky
- GRA __
- $a Pa771/17-1 $p Deutsche Forschungsgemeinschaft
- GRA __
- $a UNCE 204025/2012 $p Grantová Agentura, Univerzita Karlova
- GRA __
- $a LTC17065 $p Ministry of Education, Youth and Sports of the Czech Republic
- GRA __
- $a POLYMAT LO1507 $p Ministry of Education, Youth and Sports of CR
- GRA __
- $a 17-13283S $p Grantová Agentura České Republiky
- LZP __
- $a Pubmed-20200511